Nintedanib Alternatives Compared
| Nintedanib | Ofev (nintedanib) | Esbriet (pirfenidone) |
|
|---|
| Nintedanib | Ofev (nintedanib) | Esbriet (pirfenidone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease. Nintedanib may also be... View more |
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis, Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease. Ofev may also be used... View more |
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis. Esbriet may also be used for purposes not listed in this medication guide. |
Related suggestions Idiopathic Pulmonary Fibrosis
|
|||||||||||||||
| More about Nintedanib | More about Ofev (nintedanib) | More about Esbriet (pirfenidone) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Nintedanib has an average rating of 7.7 out of 10 from a total of 36 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 6% reported a negative effect. |
Ofev has an average rating of 7.6 out of 10 from a total of 27 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 7% reported a negative effect. |
Esbriet has an average rating of 7.5 out of 10 from a total of 11 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Nintedanib side effects |
View all Ofev side effects |
View all Esbriet side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ofev prices |
View all Esbriet prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Ofev |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
9.5 hours |
9.5 hours |
3 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 249 drugs are known to interact with Nintedanib:
|
A total of 249 drugs are known to interact with Ofev:
|
A total of 153 drugs are known to interact with Esbriet:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
October 15, 2014 |
October 15, 2014 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.